Advertisement

Topics

Scar - Pipeline Review, H1 2015

01:13 EDT 15 Apr 2015 | BioPortfolio Reports

Recently added to the BioPortfolio report store, Scar - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-03-10. This 104-page report is available in PDF from $2000.

Scar - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Scar - Pipeline Review, H1 2015’, provides an overview of the Scar’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Scar, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Scar and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Scar
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Scar and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Scar products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Scar pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and…

Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Scar Overview 9
Therapeutics Development 10
Pipeline Products for Scar - Overview 10
Pipeline Products for Scar - Comparative Analysis 11
Scar - Therapeutics under Development by Companies 12
Scar - Therapeutics under Investigation by Universities/Institutes 14
Scar - Pipeline Products Glance 15
Late Stage Products 15
Clinical Stage Products 16
Early Stage Products 17
Scar - Products under Development by Companies 18
Scar - Products under Investigation by Universities/Institutes 20
Scar - Companies Involved in Therapeutics Development 21
3M Drug Delivery Systems 21
AlbireoPharma 22
Altacor Ltd. 23
Amakem NV 24
Beech Tree Labs, Inc. 25
Biomolecular Therapeutics GmbH 26
BiOrion Technologies B.V. 27
Clanotech AB 28
Critical Outcome Technologies Inc. 29
Derma Sciences, Inc. 30
Easton Pharmaceuticals Inc. 31
Escape Therapeutics, Inc. 32
EyeGene, Inc. 33
Fibrocell Science, Inc. 34
FirstString Research, Inc. 35
Juventas Therapeutics, Inc. 36
Kasiak Research Pvt. Ltd. 37
Pergamum AB 38
RXi Pharmaceuticals Corporation 39
Symic Biomedical, Inc. 40
Scar - Therapeutics Assessment 41
Assessment by Monotherapy Products 41
Assessment by Target 42
Assessment by Mechanism of Action 44
Assessment by Route of Administration 46
Assessment by Molecule Type 48
Drug Profiles 50
A-3914 - Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
A-5425 - Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
AMA-0526 - Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
azficel-T - Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
BMT-101 - Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
BOT-191 - Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
BTL-slo - Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
CLT-28643 - Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
CM-101 - Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
decorin - Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
Drug to Agonize Beta 2 Receptor for Wound Scars - Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
DSC-127 - Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
EGS-001 - Drug Profile 63 For more information open Scar - Pipeline Review, H1 2015.

SKU: GMDHC6266IDB

Original Article: Scar - Pipeline Review, H1 2015

NEXT ARTICLE

More From BioPortfolio on "Scar - Pipeline Review, H1 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...